Previous
Next
Innovative Medicine Backed by the Power of
BioXcel Therapeutics, Inc. is a
biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches.
Innovative Medicine
Backed by the
Power of
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Innovative Medicine
Backed by the Power of
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Our Approach to Drug Development
- Optimizes R&D Economics
- Shortens Development Timelines
- Increases Probability of Success
AI-based Drug Development
Our neuroscience and immuno-oncology franchises utilize our AI
approach to drug identification and development
Neuroscience
Immuno-Oncology
Nov 14, 2022
BioXcel Therapeutics to Present at Two Upcoming Investor ConferencesVIEW RELEASE
Nov 10, 2022
BioXcel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Operational HighlightsVIEW RELEASE
Oct 27, 2022
BioXcel Therapeutics to Report Third Quarter 2022 Financial Results on November 10, 2022VIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
Nov 25, 2022 01:00 PM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
15.61
CHANGE
0.1 (0.64%)
